AstraZeneca Plc is making a final push to protect a drug that makes $7 million a day in the U.S. against cheaper copies as pressure mounts on the U.K. drugmaker to meet its own projections of almost doubling revenue.
The business of diagnostic treatments and personalized medicine got a boost Tuesday after an appeals court made it harder to invalidate certain patents by claiming they simply cover laws of nature.
Wells Fargo & Co. got less than it wanted in a federal tax-refund lawsuit, yet the bank’s partial victory may spur billions of dollars in similar refund claims from companies that have done repeated mergers and acquisitions, tax lawyers say.
The U.S. charged 301 people this year in a series of medical fraud sting operations, the most ever, for allegedly running scams that bilked the government out of $900 million.
U.S. Supreme Court Justice Samuel Alito has finally sold the Exxon Mobil Corp. stock that for almost a decade kept him from taking part in cases involving the world’s biggest publicly traded oil company.
A federal judge struck down the Obama administration’s signature effort to regulate hydraulic fracturing on public lands, putting another of the president’s environmental initiatives in legal limbo months before he leaves office.
A divided U.S. Supreme Court threw out a European Union suit that accused Reynolds American Inc. of orchestrating a global scheme to launder drug money, in a ruling that limits the reach of a federal racketeering law that can impose heavy damage awards.
The U.S. Supreme Court upheld a system that has helped companies like Google Inc. and Apple Inc. invalidate hundreds of disputed patents without having to go to court.
The trial over whether Led Zeppelin’s Jimmy Page and Robert Plant stole the iconic opening riff to “Stairway to Heaven" opened with testimony about when the British rockers might have heard the 1968 song they’re accused of copying.
Anyone with internet access can listen for themselves to whether Led Zeppelin’s opening “Stairway to Heaven” riff rips off a song recorded three years earlier. But the jury deciding the fate of the rock masterpiece — and its millions of dollars in royalties — won’t hear a simple mash-up with the obscure 1968 instrumental “Taurus” by the group Spirit.
Proving to jurors that FedEx Corp. is a criminal because it delivered illegal prescriptions from Internet drug stores was never going to be easy. Convincing a federal judge who questioned the “novel prosecution” may be even tougher.
A new approach promoted by the federal Agency for Healthcare Research and Quality is explicitly aimed at saving hospitals money on malpractice litigation while encouraging more robust scrutiny of what went wrong.
Just a handful of people find themselves in Jim Geer’s position, forbidden by the government from pursuing ideas laid out in patent applications due to national-security concerns.
Merck & Co.’s $200 million jury verdict against Gilead Sciences Inc. was voided in a patent dispute over a breakthrough for hepatitis C because of misconduct by a witness at the companies’ trial.
Two opinions released Monday by the U.S. Supreme Court hinted that conservative Justice Clarence Thomas is likely to be the author of the decision expected within weeks in a closely watched case affecting Puerto Rico’s financial future.
Billionaire brothers Charles and David Koch have made plenty of good business decisions over the years. Placing millions of dollars with Ponzi-scheme mastermind Bernard Madoff may have been one of them.
Dell Inc. shareholders who thought they were fleeced by the deal that took the computer maker private in 2013 have scored a rare — though hollow — legal victory.
Donald J. Trump claimed he’ll win a lawsuit alleging his namesake real-estate school swindled students as documents unsealed in a related racketeering case showed the hard sell given hesitant prospects.
The case tests the U.S. False Claims Act, the law that lets whistle-blowers sue on behalf of the federal government and then collect a share of any funds recovered.
Uber Technologies Inc. is trying to force an antitrust suit over the company’s surge-pricing algorithm into arbitration, arguing the class-action case is attempting to dodge a ban on customers taking disputes to court.